Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
China
· Delayed Price · Currency is CNY 61.22
-1.49 (-2.38%)
Mar 9, 2026, 3:00 PM CST
SHA:688131 Market Cap
SHA:688131 has a market cap or net worth of 12.98 billion as of March 9, 2026. Its market cap has increased by 49.24% in one year.
Market Cap
12.98B
Enterprise Value
13.72B
Revenue
2.87B
Ranking
n/a
PE Ratio
52.32
Stock Price
61.22
Market Cap Chart
Since June 8, 2021, SHA:688131's market cap has decreased from 23.30B to 12.98B, a decrease of -44.27%. That is a compound annual growth rate of -11.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 12.98B | -15.07% |
| Dec 31, 2025 | 15.29B | 103.03% |
| Dec 31, 2024 | 7.53B | -3.82% |
| Dec 29, 2023 | 7.83B | -32.18% |
| Dec 30, 2022 | 11.54B | -37.56% |
| Dec 31, 2021 | 18.49B | -20.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Chipscreen Biosciences | 13.35B |
| Guangdong Taienkang Pharmaceutical | 12.50B |
| Zhejiang Jingxin Pharmaceutical | 12.50B |
| Beijing Aosaikang Pharmaceutical | 13.58B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.68B |
| Henan Lingrui Pharmaceutical | 12.11B |
| Zhejiang Hisun Pharmaceutical | 12.06B |
| Zhejiang Hisoar Pharmaceutical | 11.87B |